dalteparin has been researched along with Brain Swelling in 5 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suto, Y | 1 |
| Nagata, K | 2 |
| Ahmed, SM | 1 |
| Jacovides, CL | 1 |
| Browne, KD | 3 |
| Cognetti, J | 1 |
| Johnson, VE | 3 |
| Leone, R | 1 |
| Kaplan, LJ | 1 |
| Smith, DH | 3 |
| Pascual, JL | 3 |
| Li, S | 2 |
| Marks, JA | 1 |
| Eisenstadt, R | 2 |
| Kumasaka, K | 2 |
| Samadi, D | 1 |
| Holena, DN | 1 |
| Allen, SR | 1 |
| Marks, J | 1 |
| Wahl, F | 2 |
| Grosjean-Piot, O | 2 |
| Bareyre, F | 1 |
| Uzan, A | 2 |
| Stutzmann, JM | 2 |
| Mary, V | 1 |
| Pratt, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine[NCT04507178] | Phase 2 | 100 participants (Anticipated) | Interventional | 2022-02-02 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dalteparin and Brain Swelling
| Article | Year |
|---|---|
Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review.
Topics: Animals; Anticoagulants; Brain Edema; Brain Injuries; Brain Ischemia; Cognition Disorders; Enoxapari | 2002 |
4 other studies available for dalteparin and Brain Swelling
| Article | Year |
|---|---|
Cerebral Edema and Neurological Recovery after Traumatic Brain Injury Are Worsened if Accompanied by a Concomitant Long Bone Fracture.
Topics: Animals; Anticoagulants; Brain Edema; Brain Injuries, Traumatic; Enoxaparin; Fractures, Bone; Male; | 2019 |
Enoxaparin ameliorates post-traumatic brain injury edema and neurologic recovery, reducing cerebral leukocyte endothelial interactions and vessel permeability in vivo.
Topics: Animals; Anticoagulants; Brain Edema; Brain Injuries; Endothelium, Vascular; Enoxaparin; Leukocytes; | 2015 |
Does enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery.
Topics: Animals; Antibodies, Monoclonal; Anticoagulants; Brain; Brain Edema; Brain Injuries; Cerebrovascular | 2016 |
Enoxaparin reduces brain edema, cerebral lesions, and improves motor and cognitive impairments induced by a traumatic brain injury in rats.
Topics: Animals; Anticoagulants; Body Water; Brain; Brain Edema; Brain Injuries; Cognition; Cognition Disord | 2000 |